| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $21,543,963 ) (Continued on the next page) |
| | 2022 | 2022 | Boston Medical Center Corporation | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | MC142074 | Behavioral Health Workforce Education and Training Program- American Rescue Plan | 00 | 2 | HRSA | 5/13/2022 | $470,099 |
| | 2022 | 2022 | Boston Medical Center Corporation | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | T2537593 | Addiction Medicine Fellowship | 00 | 3 | HRSA | 5/10/2022 | $785,601 |
| | 2022 | 2022 | Boston Medical Center Corporation | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | T3442136 | Primary Care Training and Enhancement-Community Prevention and Maternal Health | 00 | 2 | HRSA | 5/12/2022 | $592,191 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | S10OD032333 | Sartorious Octet R8 System | 000 | 1 | NIH | 6/17/2022 | $249,082 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL155451 | Targeting PGC-1a for the treatment of sickle cell disease | 000 | 1 | NIH | 6/8/2022 | $350,000 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DA052821 | Perinatal care as a venue to reduce opioid overdoses and hepatitis C virus incidence (PreVenT OD HCV) | 000 | 1 | NIH | 5/11/2022 | $175,574 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DK133404 | Investigation of the role of VEGFA in harnessing cholangiocyte-driven liver regeneration | 000 | 1 | NIH | 5/31/2022 | $596,381 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DA052674 | Tailored Contraceptive Decision Support for Pregnant Women with Opioid Use Disorder | 000 | 1 | NIH | 4/14/2022 | $189,431 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH127308 | Adaptation and assessment of a common element treatment protocol designed to improve mental health in forcibly displaced populations | 000 | 1 | NIH | 3/31/2022 | $187,689 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01CA271145 | Improving PRO Interpretation at the Individual Level for Patients with Cancer using Conversational Agents and Data Visualization | 000 | 1 | NIH | 2/18/2022 | $713,039 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23MH128639 | Medicaid Accountable Care Organizations (ACO) and Quality of Care for Adults with Serious Mental Illness (SMI) | 000 | 1 | NIH | 3/14/2022 | $189,432 |
| | 2022 | 2022 | Boston Medical Center Corporation | 1 Boston Medical Ctr Pl Ste 1 | Boston | MA | 02118-2908 | SUFFOLK | USA | T7731739 | Developmental-Behavioral Pediatrics Training Program | 00 | 5 | HRSA | 5/19/2022 | $186,684 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01HL151902 | Building methods to assess and address cardiovascular health in transgender adults | 000 | 2 | NIH | 3/24/2022 | $166,320 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23NS116033 | Dynamic Risk Prediction of Life-Threatening Mass Effect After Ischemic Stroke | 000 | 2 | NIH | 4/1/2022 | $186,515 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R21DA053307 | Identifying and Testing Post-Overdose Outreach Adaptations to Enhance Survivor Engagement During the COVID-19 Pandemic | 001 | 2 | NIH | 5/19/2022 | $230,102 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DA054363 | Retention and Re-Engagement in Treatment for Addiction following Serious Injection Related Infections (RETAIN) | 000 | 2 | NIH | 5/19/2022 | $189,432 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MD015165 | Multilevel Physical Activity Intervention for Low Income Public Housing Residents | 002 | 2 | NIH | 4/29/2022 | $68,488 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MD015165 | Multilevel Physical Activity Intervention for Low Income Public Housing Residents | 001 | 2 | NIH | 3/24/2022 | $616,390 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32AI052074 | BU Clinical HIV/AIDS Research Training Program (BU-CHART | 004 | 17 | NIH | 6/2/2022 | $249,697 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R25DA033211 | Advancing Clinical Research Training within Addiction Residency Programs | 000 | 10 | NIH | 2/2/2022 | $317,330 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32HS022242 | Training in Health Services Research for Vulnerable Populations | 000 | 10 | AHRQ | 6/17/2022 | $401,515 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01MH109651 | Elucidating mechanistic connections between guidance signaling, microtubule regulation, and growth cone steering | 001 | 6 | NIH | 1/13/2022 | $448,494 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HD090191 | Implementing an Intervention to Address Social Determinants of Health in Pediatric Practices | 001 | 5 | NIH | 4/19/2022 | $54,777 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HD090191 | Implementing an Intervention to Address Social Determinants of Health in Pediatric Practices | 000 | 5 | NIH | 1/20/2022 | $492,994 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01EY027082 | Mitochondrial fragmentation and dysfunction in diabetic retinopathy | 000 | 5 | NIH | 2/4/2022 | $431,650 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA046527 | Researching Effective Strategies to Prevent Opioid Death (RESPOND) | 000 | 5 | NIH | 3/17/2022 | $686,510 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK113252 | Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community | 000 | 5 | NIH | 11/17/2021 | $188,447 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32MH116140 | Boston University Medical Campus-Massachusetts General Hospital Global Psychiatric Clinical Research Training Program | 000 | 5 | NIH | 5/17/2022 | $307,170 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | T32MH116140 | Boston University Medical Campus-Massachusetts General Hospital Global Psychiatric Clinical Research Training Program | 000 | 5 | NIH | 5/17/2022 | $4,909 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AI138960 | Signals that establish and maintain HIV latency | 000 | 5 | NIH | 4/27/2022 | $436,294 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DA044085 | Engaging Young People who Inject Drugs into HCV and HIV Care | 000 | 5 | NIH | 4/13/2022 | $181,472 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | UM1DA049412 | MassHEAL - Reducing overdose deaths by 40% (2019-2023) | 002 | 4 | NIH | 4/15/2022 | $67,800 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | UM1DA049412 | MassHEAL - Reducing overdose deaths by 40% (2019-2023) | 001 | 4 | NIH | 4/14/2022 | $3,000,000 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K24AI145661 | HIV-1 mucosal transmission and persistence | 000 | 4 | NIH | 3/24/2022 | $181,673 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HD096798 | Safety, pharmacokinetics and efficacy of extended-release naltrexone in pregnant women with opioid use disorder | 000 | 5 | NIH | 5/9/2022 | $613,662 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL141774 | Understanding and Addressing the Social Determinants of Health for Families of Children with Sickle Cell Anemia within Pediatric Hematology | 000 | 4 | NIH | 3/14/2022 | $721,495 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01HL141774 | Understanding and Addressing the Social Determinants of Health for Families of Children with Sickle Cell Anemia within Pediatric Hematology | 001 | 4 | NIH | 3/17/2022 | $77,320 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01CA238335 | Digital Health Supported Weight Management Intervention Delivered by Community Health Workers among Public Housing Residents | 000 | 3 | NIH | 2/18/2022 | $615,409 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01CA238335 | Digital Health Supported Weight Management Intervention Delivered by Community Health Workers among Public Housing Residents | 001 | 3 | NIH | 4/25/2022 | $54,705 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23ES028736 | Effects of maternal thyroid function and thyroidal disruptor exposure on pregnancy and child developmental outcomes | 000 | 4 | NIH | 5/31/2022 | $205,326 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DE029862 | Validation of Light Scattering Spectroscopy for Intra-operative Margin Guidance during Oral Cancer Resection | 000 | 3 | NIH | 5/31/2022 | $709,868 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK119542 | The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 Nephropathy | 000 | 3 | NIH | 4/12/2022 | $185,204 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23DK119542 | The Role of Dietary Nutrients in Chronic Kidney Disease Progression and Apolipoprotein L1 Nephropathy | 001 | 3 | NIH | 5/27/2022 | $0 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01AG066892 | Improving Medical Decision Making for Older Patients with End Stage Renal Disease | 000 | 3 | NIH | 5/26/2022 | $2,180,636 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NR018400 | I kua na'u "Let Me Carry Out Your Last Wishes" Advance Care Planning for Native Hawaiian Elders | 000 | 3 | NIH | 2/10/2022 | $611,298 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01NR018400 | I kua na'u "Let Me Carry Out Your Last Wishes" Advance Care Planning for Native Hawaiian Elders | 001 | 3 | NIH | 4/20/2022 | $67,922 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K01DA054328 | Improving value-based healthcare delivery for opioid use disorder | 000 | 2 | NIH | 5/24/2022 | $175,889 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | R01DA055488 | Persistent HIV-1 expression and microglia dysfunction | 000 | 2 | NIH | 5/19/2022 | $739,881 |
| | 2022 | 2022 | BOSTON MEDICAL CENTER CORPORATION | 1 BOSTON MEDICAL CTR PL STE 1 | BOSTON | MA | 02118-2908 | SUFFOLK | USA | K23AI152930 | Understanding HIV's impact on RR/MDR-TB development and transmission through genomics | 000 | 2 | NIH | 5/17/2022 | $187,485 |
|
